Company Search:
Advanced Search
Sponsored Links
Immunomedics, Inc. Company Snapshot
Immunomedics, Inc. operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immunomedics with three other companies in this sector in the United States: Akers Biosciences Incorporation (2016 sales of $2.96 million of which 100% was Diagnostic Screening), Vermillion Inc ($2.64 million of which 100% was Novel Diagnostic Test), and Interleukin Genetics, Inc. ($2.51 million ).

Sales Analysis. During the year ended June of 2016, sales at Immunomedics were $3.23 million. This is a sharp decrease of 42.8% versus 2015, when the company's sales were $5.65 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Immunomedics, Inc.
  Stock Performance Chart for Immunomedics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 9.05
(Figures in U.S. Dollars)
1 Week 7.5%   13 Weeks 21.0%  
4 Weeks 52.1%   52 Weeks 296.9%  
Immunomedics, Inc. Key Data:
  Ticker: IMMU Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2016 Sales 3,233,247
(Year Ending Jan 2017).
Employees: 131
  Currency: U.S. Dollars Market Cap: 997,880,838
  Fiscal Yr Ends: June Shares Outstanding: 110,263,076
  Share Type: Common Closely Held Shares: 6,243,139
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.